Literature DB >> 2421526

Bradykinin accelerates mucociliary activity in rabbit maxillary sinus.

S Lindberg, U Mercke.   

Abstract

The in vivo effect of bradykinin on mucociliary (m.c.) activity in the rabbit maxillary sinus was investigated by administering the substance (0.01-10.0 micrograms/kg) via arteria maxillaris and recording the responses with a non-invasive photoelectric technique. Bradykinin accelerated the m.c. activity in a dose-dependent manner in the dose range 0.05-10.0 micrograms/kg. While the action of bradykinin was resistant to pretreatment with indomethacin 10.0 mg/kg, it was considerably weakened by the substance P antagonist [D-Pro2, D-Trp7,9]SP 1 mg/kg. The initial effect of bradykinin was also suppressed by atropine, suggesting that bradykinin accelerates m.c. activity by a dual mechanism comprising both SP and acetylcholine. Bradykinin probably stimulates a reflex arc in the airways involving afferent SP neurons and efferent post-ganglionic parasympathetic neurons.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2421526     DOI: 10.3109/00016488609108613

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  3 in total

1.  The effect of middle ear effusions from children on in vitro ciliary activity.

Authors:  K Takeuchi; S Saida; Y Majima; Y Sakakura
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

2.  Regulatory pathways for the stimulation of canine tracheal ciliary beat frequency by bradykinin.

Authors:  L B Wong; I F Miller; D B Yeates
Journal:  J Physiol       Date:  1990-03       Impact factor: 5.182

3.  Mycoplasma hyopneumoniae surface-associated proteases cleave bradykinin, substance P, neurokinin A and neuropeptide Y.

Authors:  Veronica Maria Jarocki; Benjamin Bernard Armando Raymond; Jessica Leigh Tacchi; Matthew Paul Padula; Steven Philip Djordjevic
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.